FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Christina Aquilante

Research Profile

Occupations

Pharmacogenetics

Physiology

Chemicals & Drugs

Genes & Molecular Sequences

Disorders

Procedures

Sequence Analysis, DNA

Concepts & Ideas

Time Factors

Co-author Network

Publications

TOP 3
Christina L Aquilante; David W A Bourne; Lane Bushman; Elizabeth B Daily; Kyle P Hammond; Charles W Hopley; Rajendra Shriram Kadam; Alexander T Kanack; Uday B Kompella; Lisa A Kosmiski; Merry Le; Julie A Predhomme; Joseph E Rower; Maha S Sidhom
Impact of the CYP2C8 *3 polymorphism on the drug-drug interaction between gemfibrozil and pioglitazone.
Christina L Aquilante; Uwe Christians; Elizabeth B Daily; Keith L Hoffman; Charles W Hopley; Jennifer J Kiser; Lisa A Kosmiski; Julie A Predhomme; Bjorn Schniedewind; Peter L Anderson; Maha S Sidhom
Influence of SLCO1B1 polymorphisms on the drug-drug interaction between darunavir/ritonavir and pravastatin.
Deidre A Kile; Samantha MaWhinney; Joseph E Rower; Christina L Aquilante; Jose R Castillo-Mancilla; Peter L Anderson
A population pharmacokinetic-pharmacogenetic analysis of atazanavir.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Christina Aquilante (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Christina L Aquilante; David W A Bourne; Lane Bushman; Elizabeth B Daily; Kyle P Hammond; Charles W Hopley; Rajendra Shriram Kadam; Alexander T Kanack; Uday B Kompella; Lisa A Kosmiski; Merry Le; Julie A Predhomme; Joseph E Rower; Maha S Sidhom
Impact of the CYP2C8 *3 polymorphism on the drug-drug interaction between gemfibrozil and pioglitazone.
British journal of clinical pharmacology 2013;75(1):217-26.
2012: Christina L Aquilante; Uwe Christians; Elizabeth B Daily; Keith L Hoffman; Charles W Hopley; Jennifer J Kiser; Lisa A Kosmiski; Julie A Predhomme; Bjorn Schniedewind; Peter L Anderson; Maha S Sidhom
Influence of SLCO1B1 polymorphisms on the drug-drug interaction between darunavir/ritonavir and pravastatin.
Journal of clinical pharmacology 2012;52(11):1725-38.
2012: Deidre A Kile; Samantha MaWhinney; Joseph E Rower; Christina L Aquilante; Jose R Castillo-Mancilla; Peter L Anderson
A population pharmacokinetic-pharmacogenetic analysis of atazanavir.
AIDS research and human retroviruses 2012;28(10):1227-34.
2012: Amber L Beitelshees; Taimour Y Langaee; Richard S Schofield; Gregory J Welder; Hooman Allayee; Christina L Aquilante; Issam Zineh
CXCL5 polymorphisms are associated with variable blood pressure in cardiovascular disease-free adults.
Human genomics 2012;6():9.
2010: Joseph E Rower; Lane Bushman; Kyle P Hammond; Rajendra Shriram Kadam; Christina L Aquilante
Validation of an LC/MS method for the determination of gemfibrozil in human plasma and its application to a pharmacokinetic study.
Biomedical chromatography : BMC 2010;24(12):1300-8.
2010: Christina L Aquilante
Sulfonylurea pharmacogenomics in Type 2 diabetes: the influence of drug target and diabetes risk polymorphisms.
Expert review of cardiovascular therapy 2010;8(3):359-72.
2010: Christina L Aquilante; Lisa A Kosmiski; Issam Zineh; Lucille Capo Rome; Shannon D Knutsen
Pharmacodynamic effects of rosiglitazone in nondiabetic patients with metabolic syndrome.
Pharmacotherapy 2010;30(3):236-47.
2009: Peter L Anderson; Christina L Aquilante; Edward M Gardner; Julie Predhomme; Patrick McDaneld; Lane Bushman; Jia-Hua Zheng; Michelle Ray; Samantha MaWhinney
Atazanavir pharmacokinetics in genetically determined CYP3A5 expressors versus non-expressors.
The Journal of antimicrobial chemotherapy 2009;64(5):1071-9.
2009: Elizabeth B Daily; Christina L Aquilante
Cytochrome P450 2C8 pharmacogenetics: a review of clinical studies.
Pharmacogenomics 2009;10(9):1489-510.
2008: Christina L Aquilante; Hossein Najaf Yarandi; Larisa H Cavallari; Tara Engeman Andrisin; Steven G Terra; Jannet F Lewis; Karen K Hamilton; Julie A Johnson
Beta-adrenergic receptor gene polymorphisms and hemodynamic response to dobutamine during dobutamine stress echocardiography.
The pharmacogenomics journal 2008;8(6):408-15.
2008: Christina L Aquilante; Lane R Bushman; Shannon D Knutsen; Lauren E Burt; Lucille Capo Rome; Lisa A Kosmiski
Influence of SLCO1B1 and CYP2C8 gene polymorphisms on rosiglitazone pharmacokinetics in healthy volunteers.
Human genomics 2008;3(1):7-16.
2008: Michael A Pacanowski; Charles W Hopley; Christina L Aquilante
Interindividual variability in oral antidiabetic drug disposition and response: the role of drug transporter polymorphisms.
Expert opinion on drug metabolism & toxicology 2008;4(5):529-44.
2008: Christina L Aquilante; Lisa A Kosmiski; Shannon D Knutsen; Issam Zineh
Relationship between plasma resistin concentrations, inflammatory chemokines, and components of the metabolic syndrome in adults.
Metabolism: clinical and experimental 2008;57(4):494-501.
2008: Jennifer J Kiser; Christina L Aquilante; Peter L Anderson; Tracy M King; Monica L Carten; Courtney V Fletcher
Clinical and genetic determinants of intracellular tenofovir diphosphate concentrations in HIV-infected patients.
Journal of acquired immune deficiency syndromes (1999) 2008;47(3):298-303.
2008: Jennifer J Kiser; M L Carten; Christina L Aquilante; Peter L Anderson; Pamela Wolfe; T M King; Thomas Delahunty; Lane Bushman; Courtney V Fletcher
The effect of lopinavir/ritonavir on the renal clearance of tenofovir in HIV-infected patients.
Clinical pharmacology and therapeutics 2008;83(2):265-72.
2007: Christina L Aquilante
Pharmacogenetics of thiazolidinedione therapy.
Pharmacogenomics 2007;8(8):917-31.
2007: Christina L Aquilante; Amber L Beitelshees; Issam Zineh
Correlates of serum matrix metalloproteinase-8 (MMP-8) concentrations in nondiabetic subjects without cardiovascular disease.
Clinica chimica acta; international journal of clinical chemistry 2007;379(1-2):48-52.
2007: Christina L Aquilante; Weiming Zhang; Marianne McCollum
Race, ethnicity, and use of thiazolidinediones among US adults with diabetes.
Current medical research and opinion 2007;23(3):489-94.
2006: Christina L Aquilante; Issam Zineh; Amber L Beitelshees; Taimour Y Langaee
Common laboratory methods in pharmacogenomics studies.
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 2006;63(21):2101-10.
2006: Christina L Aquilante; Taimour Y Langaee; Peter L Anderson; Issam Zineh; Courtney V Fletcher
Multiplex PCR-pyrosequencing assay for genotyping CYP3A5 polymorphisms.
Clinica chimica acta; international journal of clinical chemistry 2006;372(1-2):195-8.
2006: Peter L Anderson; Jatinder Lamba; Christina L Aquilante; Erin Schuetz; Courtney V Fletcher
Pharmacogenetic characteristics of indinavir, zidovudine, and lamivudine therapy in HIV-infected adults: a pilot study.
Journal of acquired immune deficiency syndromes (1999) 2006;42(4):441-9.
2006: Christina L Aquilante; Steven G Terra; Richard S Schofield; Daniel F Pauly; Patricia S Hatton; philip binkley; Julie A Johnson
Sustained restoration of autonomic balance with long- but not short-acting metoprolol in patients with heart failure.
Journal of cardiac failure 2006;12(3):171-6.
2006: Issam Zineh; Glenn D Pebanco; Christina L Aquilante; Tobias Gerhard; Amber L Beitelshees; Bach Nhi Beasley; Abraham G Hartzema
Discordance between availability of pharmacogenetics studies and pharmacogenetics-based prescribing information for the top 200 drugs.
The Annals of pharmacotherapy 2006;40(4):639-44.
2006: Christina L Aquilante; Taimour Y Langaee; Larry M Lopez; Hossein Najaf Yarandi; Jennifer S Tromberg; Dagmara Mohuczy; Katherine L Gaston; Cassandra D Waddell; Mark J Chirico; Julie A Johnson
Influence of coagulation factor, vitamin K epoxide reductase complex subunit 1, and cytochrome P450 2C9 gene polymorphisms on warfarin dose requirements.
Clinical pharmacology and therapeutics 2006;79(4):291-302.
2006: Issam Zineh; Christina L Aquilante; Taimour Y Langaee; Amber L Beitelshees; Christopher B Arant; Timothy R Wessel; Richard S Schofield
CXCL5 gene polymorphisms are related to systemic concentrations and leukocyte production of epithelial neutrophil-activating peptide (ENA-78).
Cytokine 2006;33(5):258-63.
2005: Min Lin; Christina L Aquilante; Julie A Johnson; Rongling Wu
Sequencing drug response with HapMap.
The pharmacogenomics journal 2005;5(3):149-56.
2004: Christina L Aquilante; Larisa M Humma; Hossein Najaf Yarandi; Tara Engeman Andrisin; Jannet F Lewis; Karen K Hamilton; Julie A Johnson
Influence of gender and race on hemodynamic response to dobutamine during dobutamine stress echocardiography.
The American journal of cardiology 2004;94(4):535-8.
2004: Christina L Aquilante; Maximilian T Lobmeyer; Taimour Y Langaee; Julie A Johnson
Comparison of cytochrome P450 2C9 genotyping methods and implications for the clinical laboratory.
Pharmacotherapy 2004;24(6):720-6.
2004: Issam Zineh; Tobias Gerhard; Christina L Aquilante; Amber L Beitelshees; B N Beasley; Abraham G Hartzema
Availability of pharmacogenomics-based prescribing information in drug package inserts for currently approved drugs.
The pharmacogenomics journal 2004;4(6):354-8.